Protein Name |
Pfam ID |
Percentage of Identity (%) |
E value |
Mixed lineage kinase 1 (MAP3K9)
|
|
29.431 (88/299) |
3.66E-27 |
MST-1 protein kinase (STK4)
|
|
26.736 (77/288) |
2.53E-23 |
NIMA-related kinase 7 (NEK7)
|
|
25.714 (72/280) |
1.41E-22 |
Serine/threonine-protein kinase 3 (STK3)
|
|
26.389 (76/288) |
3.73E-22 |
Omphalocele kinase 1 (NUAK1)
|
|
28.723 (81/282) |
5.51E-22 |
Ribosomal protein S6 kinase alpha-2 (RSK2)
|
|
28.938 (79/273) |
6.49E-22 |
Serine/threonine-protein kinase 24 (STK24)
|
|
27.007 (74/274) |
2.09E-21 |
Ribosomal protein S6 kinase alpha-3 (RSK3)
|
|
28.832 (79/274) |
1.09E-20 |
NIMA-related kinase 6 (NEK6)
|
|
23.875 (69/289) |
2.11E-20 |
Ribosomal protein S6 kinase alpha-1 (RSK1)
|
|
28.205 (77/273) |
4.36E-20 |
Ribosomal protein S6 kinase alpha-6 (RSK6)
|
|
27.536 (76/276) |
4.82E-20 |
Microtubule affinity regulating kinase 3 (MARK3)
|
|
30.208 (87/288) |
6.41E-20 |
Serine/threonine-protein kinase 33 (STK33)
|
|
28.016 (72/257) |
1.28E-19 |
Oxidative stress responsive 1 (OXSR1)
|
|
23.885 (75/314) |
1.43E-19 |
Serine/threonine-protein kinase Nek5 (NEK5)
|
|
24.101 (67/278) |
2.20E-19 |
Ste-20-related kinase (STK39)
|
|
26.498 (84/317) |
2.41E-19 |
Serine/threonine-protein kinase 10 (STK10)
|
|
26.277 (72/274) |
4.13E-19 |
NUAK family SNF1-like kinase 2 (NUAK2)
|
|
27.402 (77/281) |
5.39E-19 |
Serine/threonine-protein kinase MARK1 (MARK1)
|
|
31.197 (73/234) |
8.06E-19 |
Unc-51 like kinase 3 (ULK3)
|
|
25.806 (80/310) |
8.85E-19 |
Testis-specific serine kinase 2 (TSSK2)
|
|
27.305 (77/282) |
1.31E-18 |
Leucine-rich repeat kinase 2 (LRRK2)
|
|
28.947 (88/304) |
2.49E-18 |
Salt-inducible kinase 2 (SIK2)
|
|
29.603 (82/277) |
3.74E-18 |
Testis-specific serine/threonine-protein kinase 6 (TSSK6)
|
|
27.273 (78/286) |
5.19E-18 |
MAP/microtubule affinity-regulating kinase 4 (MARK4)
|
|
30.342 (71/234) |
5.37E-18 |
Serine/threonine-protein kinase MARK2 (MARK2)
|
|
29.514 (85/288) |
6.23E-18 |
Serine/threonine-protein kinase 26 (STK26)
|
|
26.596 (75/282) |
1.04E-17 |
Serine/threonine-protein kinase 25 (STK25)
|
|
25.547 (70/274) |
1.22E-17 |
ERK activator kinase 2 (MEK2)
|
|
28.879 (67/232) |
1.64E-17 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 (PRKAA1)
|
|
27.950 (90/322) |
1.67E-17 |
Putative 3-phosphoinositide-dependent protein kinase 2 (PDPK2P)
|
|
26.860 (65/242) |
4.01E-17 |
STE20-related serine/threonine-protein kinase (SLK)
|
|
27.642 (68/246) |
4.12E-17 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 (PRKAA2)
|
|
28.014 (79/282) |
4.34E-17 |
Phosphoinositide dependent protein kinase-1 (PDPK1)
|
|
27.935 (69/247) |
5.28E-17 |
Putative serine/threonine-protein kinase SIK1B (SIK1B)
|
|
26.978 (75/278) |
5.92E-17 |
Salt-inducible kinase 1 (SIK1)
|
|
26.978 (75/278) |
6.24E-17 |
RAC-beta serine/threonine-protein kinase (AKT2)
|
|
26.667 (72/270) |
1.08E-16 |
PAK-2 protein kinase (PAK2)
|
|
22.910 (74/323) |
1.36E-16 |
Fused homolog (STK36)
|
|
26.754 (61/228) |
1.41E-16 |
Protein kinase C theta (PRKCQ)
|
|
25.071 (88/351) |
2.02E-16 |
ERK activator kinase 1 (MEK1)
|
|
27.193 (62/228) |
3.13E-16 |
Aurora kinase A (AURKA)
|
|
22.923 (80/349) |
3.37E-16 |
RAC-gamma serine/threonine-protein kinase (AKT3)
|
|
26.667 (72/270) |
4.58E-16 |
Leucine-rich repeat serine/threonine-protein kinase 1 (LRRK1)
|
|
26.452 (82/310) |
5.19E-16 |
Myosin-IIIb (MYO3B)
|
|
27.931 (81/290) |
6.17E-16 |
SPS1/STE20-related protein kinase YSK4 (YSK4)
|
|
26.071 (73/280) |
6.66E-16 |
ERK activator kinase 5 (MAP2K5)
|
|
24.633 (84/341) |
9.20E-16 |
RAC-alpha serine/threonine-protein kinase (AKT1)
|
|
25.656 (88/343) |
1.08E-15 |
Apoptosis signal-regulating kinase 1 (MAP3K5)
|
|
26.596 (75/282) |
1.83E-15 |
Serine/threonine-protein kinase Nek8 (NEK8)
|
|
27.437 (76/277) |
2.81E-15 |
cAMP-dependent protein kinase catalytic subunit beta (PRKACB)
|
|
24.573 (72/293) |
2.84E-15 |
Serine/threonine-protein kinase ULK1 (ULK1)
|
|
27.799 (72/259) |
3.18E-15 |
Calcium/calmodulin-dependent protein kinase type 1 (CAMK1)
|
|
26.621 (78/293) |
3.70E-15 |
Polo-like kinase 2 (PLK2)
|
|
22.789 (67/294) |
3.87E-15 |
Testis-specific serine/threonine-protein kinase 1 (TSSK1B)
|
|
26.241 (74/282) |
4.47E-15 |
Serine/threonine-protein kinase PAK 3 (PAK3)
|
|
23.022 (64/278) |
5.60E-15 |
Myosin light chain kinase family member 4 (MYLK4)
|
|
25.084 (75/299) |
5.63E-15 |
Ribosomal protein S6 kinase beta-1 (S6K1)
|
|
27.119 (64/236) |
6.70E-15 |
Inhibitor of nuclear factor kappa-B kinase beta (IKKB)
|
|
25.738 (61/237) |
9.86E-15 |
SIK family kinase 3 (SIK3)
|
|
26.429 (74/280) |
1.05E-14 |
Serine/threonine-protein kinase Nek3 (NEK3)
|
|
22.993 (63/274) |
1.06E-14 |
PAK-1 protein kinase (PAK1)
|
|
22.662 (63/278) |
1.20E-14 |
cAMP-dependent protein kinase catalytic subunit alpha (PRKACA)
|
|
25.161 (78/310) |
1.26E-14 |
Serine/threonine-protein kinase Nek4 (NEK4)
|
|
24.746 (73/295) |
1.49E-14 |
Serine/threonine-protein kinase Sgk1 (SGK1)
|
|
24.063 (77/320) |
1.51E-14 |
Serine/threonine-protein kinase ULK2 (ULK2)
|
|
25.292 (65/257) |
1.75E-14 |
MAPK/ERK kinase kinase 1 (MAP3K1)
|
|
22.517 (68/302) |
1.84E-14 |
Serine/threonine-protein kinase PAK 5 (PAK5)
|
|
26.182 (72/275) |
1.85E-14 |
Dual specificity mitogen-activated protein kinase kinase 4 (MAP2K4)
|
|
23.861 (89/373) |
1.96E-14 |
Myosin light chain kinase 3 (MYLK3)
|
|
28.696 (66/230) |
2.21E-14 |
Myosin light chain kinase 2 (MYLK2)
|
|
28.629 (71/248) |
2.63E-14 |
PKC-delta-interacting protein kinase (RIPK4)
|
|
26.370 (77/292) |
2.75E-14 |
Serine/threonine-protein kinase Nek11 (NEK11)
|
|
24.370 (58/238) |
3.85E-14 |
Cyclin-dependent kinase-like 4 (CDKL4)
|
|
25.322 (59/233) |
4.08E-14 |
Protein kinase C delta (PRKCD)
|
|
26.259 (73/278) |
4.58E-14 |
Serine/threonine-protein kinase NIM1 (NIM1K)
|
|
27.459 (67/244) |
4.79E-14 |
cAMP-dependent protein kinase catalytic subunit gamma (PRKACG)
|
|
24.549 (68/277) |
6.10E-14 |
Serine/threonine-protein kinase STK11 (STK11)
|
|
23.826 (71/298) |
6.83E-14 |
Protein kinase N2 (PKN2)
|
|
25.524 (73/286) |
7.64E-14 |
Calcium/calmodulin-dependent protein kinase type 1G (CAMK1G)
|
|
27.113 (77/284) |
9.34E-14 |
Mitogen-activated protein kinase kinase kinase 15 (MAP3K15)
|
|
26.241 (74/282) |
9.64E-14 |
Serine/threonine-protein kinase Nek10 (NEK10)
|
|
24.359 (76/312) |
9.75E-14 |
Cyclin-dependent kinase 2 (CDK2)
|
|
24.896 (60/241) |
1.16E-13 |
BR serine/threonine kinase 1 (BRSK1)
|
|
26.667 (76/285) |
1.18E-13 |
Serine/threonine-protein kinase PAK 6 (PAK6)
|
|
26.754 (61/228) |
1.21E-13 |
NIMA-related kinase 2 (NEK2)
|
|
22.973 (68/296) |
1.22E-13 |
Myosin-IIIa (MYO3A)
|
|
25.952 (75/289) |
1.35E-13 |
Cyclin-dependent kinase 6 (CDK6)
|
|
26.126 (58/222) |
1.35E-13 |
Cyclin-dependent kinase 5 (CDK5)
|
|
24.903 (64/257) |
1.41E-13 |
Doublecortin-like kinase 3 (DCLK3)
|
|
27.719 (79/285) |
1.77E-13 |
Serine/threonine-protein kinase ICK (CILK1)
|
|
27.803 (62/223) |
1.94E-13 |
Ribosomal protein S6 kinase beta-2 (RPS6KB2)
|
|
24.014 (67/279) |
2.11E-13 |
Serine/threonine-protein kinase PLK3 (PLK3)
|
|
21.222 (66/311) |
2.23E-13 |
Protein kinase N1 (PKN1)
|
|
27.106 (74/273) |
2.71E-13 |
MEK kinase kinase 1 (MAP4K1)
|
|
23.675 (67/283) |
2.88E-13 |
Cyclin-dependent kinase 3 (CDK3)
|
|
25.000 (56/224) |
3.88E-13 |
Aurora kinase C (AURKC)
|
|
23.273 (64/275) |
4.50E-13 |
Testis-specific serine/threonine-protein kinase 4 (TSSK4)
|
|
27.273 (81/297) |
6.15E-13 |
Dual specificity mitogen-activated protein kinase kinase 3 (MAP2K3)
|
|
24.422 (74/303) |
6.29E-13 |
Maternal embryonic leucine zipper kinase (MELK)
|
|
25.368 (69/272) |
7.21E-13 |
Polo-like kinase 4 (PLK4)
|
|
23.381 (65/278) |
7.48E-13 |
Serine/threonine-protein kinase Nek9 (NEK9)
|
|
22.491 (65/289) |
8.34E-13 |
Cyclin-dependent kinase-like 1 (CDKL1)
|
|
26.180 (61/233) |
8.41E-13 |
Calcium/calmodulin-dependent protein kinase type 1D (CAMK1D)
|
|
26.335 (74/281) |
9.97E-13 |
Cyclin-dependent kinase-like 3 (CDKL3)
|
|
26.496 (62/234) |
1.02E-12 |
Cyclin-dependent kinase 17 (CDK17)
|
|
25.573 (67/262) |
1.03E-12 |
Polo-like kinase 1 (PLK1)
|
|
22.857 (64/280) |
1.08E-12 |
NIMA-related kinase 1 (NEK1)
|
|
24.138 (70/290) |
1.55E-12 |
BR serine/threonine kinase 2 (BRSK2)
|
|
27.074 (62/229) |
1.69E-12 |
SNF-related serine/threonine-protein kinase (SNRK)
|
|
25.806 (72/279) |
1.76E-12 |
Dual specificity mitogen-activated protein kinase kinase 6 (MAP2K6)
|
|
24.199 (68/281) |
2.26E-12 |
PAK-4 protein kinase (PAK4)
|
|
23.333 (70/300) |
2.38E-12 |
Death-associated protein kinase 1 (DAPK1)
|
|
24.476 (70/286) |
2.42E-12 |
Cyclin-dependent kinase 7 (CDK7)
|
|
24.521 (64/261) |
2.74E-12 |
Cyclin-dependent kinase 16 (CDK16)
|
|
24.615 (64/260) |
3.21E-12 |
PDZ binding kinase (PBK)
|
|
23.684 (63/266) |
3.98E-12 |
MAPK/ERK kinase kinase 3 (MAP3K3)
|
|
27.434 (62/226) |
4.46E-12 |
Calcium/calmodulin-dependent protein kinase type 1B (PNCK)
|
|
26.374 (72/273) |
4.50E-12 |
IL-1 receptor-associated kinase 1 (IRAK1)
|
|
27.039 (63/233) |
4.51E-12 |
Inhibitor of nuclear factor kappa-B kinase alpha (IKKA)
|
|
27.660 (65/235) |
4.87E-12 |
Receptor-interacting serine/threonine-protein kinase 3 (RIPK3)
|
|
26.646 (85/319) |
5.30E-12 |
Serine/threonine-protein kinase MAK (MAK)
|
|
25.225 (56/222) |
5.73E-12 |
Checkpoint kinase-1 (CHK1)
|
|
27.854 (61/219) |
5.74E-12 |
TRAF2 and NCK interacting kinase (TNIK)
|
|
25.735 (70/272) |
6.17E-12 |
Apoptosis signal-regulating kinase 2 (MAP3K6)
|
|
27.106 (74/273) |
6.82E-12 |
MAPK/ERK kinase kinase 2 (MAP3K2)
|
|
27.897 (65/233) |
8.10E-12 |
Cyclin-dependent kinase 18 (CDK18)
|
|
26.522 (61/230) |
8.65E-12 |
Cyclin-dependent kinase 1 (CDK1)
|
|
26.840 (62/231) |
8.97E-12 |
Protein kinase C alpha (PRKCA)
|
|
24.354 (66/271) |
1.01E-11 |
Serine/threonine-protein kinase H1 (PSKH1)
|
|
27.273 (66/242) |
1.02E-11 |
Nik-related protein kinase (NRK)
|
|
24.528 (78/318) |
1.07E-11 |
Protein kinase G2 (PRKG2)
|
|
23.571 (66/280) |
1.46E-11 |
Doublecortin-like kinase 1 (DCLK1)
|
|
23.929 (67/280) |
1.49E-11 |
MAPK/MAK/MRK overlapping kinase (MOK)
|
|
26.250 (63/240) |
1.53E-11 |
Protein kinase C epsilon (PRKCE)
|
|
26.160 (62/237) |
1.56E-11 |
Doublecortin-like kinase 2 (DCLK2)
|
|
24.315 (71/292) |
1.64E-11 |
Serine/threonine-protein kinase Sgk3 (SGK3)
|
|
25.322 (59/233) |
1.82E-11 |
Tyrosine-protein kinase EIF2AK2 (p68)
|
|
21.569 (66/306) |
1.86E-11 |
Cyclin-dependent kinase-like 5 (CDKL5)
|
|
23.404 (55/235) |
2.17E-11 |
Misshapen-like kinase 1 (MINK1)
|
|
25.397 (64/252) |
2.30E-11 |
Testis-specific serine/threonine-protein kinase 3 (TSSK3)
|
|
26.106 (59/226) |
2.60E-11 |
TAO kinase 3 (TAOK3)
|
|
24.910 (69/277) |
2.77E-11 |
Calmodulin-dependent kinase II (CAMKK2)
|
|
24.380 (59/242) |
2.78E-11 |
Putative serine/threonine-protein kinase PRKY (PRKY)
|
|
23.707 (55/232) |
3.88E-11 |
Proto-oncogene serine/threonine-protein kinase mos (MOS)
|
|
23.226 (72/310) |
4.38E-11 |
G protein-coupled receptor kinase 6 (GRK6)
|
|
26.991 (61/226) |
5.02E-11 |
Cyclin-dependent kinase 14 (CDK14)
|
|
24.590 (60/244) |
5.31E-11 |
Serine/threonine-protein kinase TAO2 (TAOK2)
|
|
26.906 (60/223) |
6.27E-11 |
cAMP-dependent protein kinase catalytic subunit PRKX (PRKX)
|
|
25.000 (58/232) |
6.59E-11 |
Death-associated protein kinase 3 (DAPK3)
|
|
23.427 (67/286) |
6.74E-11 |
Death-associated protein kinase 2 (DAPK2)
|
|
25.210 (60/238) |
7.37E-11 |
MAP kinase p38 (MAPK12)
|
|
26.754 (61/228) |
8.24E-11 |
TAO kinase 1 (TAOK1)
|
|
27.039 (63/233) |
1.00E-10 |
Serine/threonine-protein kinase H2 (PSKH2)
|
|
22.407 (54/241) |
1.01E-10 |
Serine/threonine-protein kinase Sgk2 (SGK2)
|
|
22.222 (72/324) |
1.18E-10 |
Aurora kinase B (AURKB)
|
|
25.439 (58/228) |
1.30E-10 |
Protein kinase G1 (PRKG1)
|
|
22.878 (62/271) |
1.59E-10 |
Protein kinase C eta type (PRKCH)
|
|
24.055 (70/291) |
1.68E-10 |
Calcium/calmodulin-dependent protein kinase type IV (CAMK4)
|
|
27.679 (62/224) |
1.74E-10 |
G protein-coupled receptor kinase 5 (GRK5)
|
|
27.391 (63/230) |
1.78E-10 |
Protein kinase C beta (PRKCB)
|
|
25.092 (68/271) |
2.41E-10 |
Serine/threonine-protein kinase PDIK1L (PDIK1L)
|
|
24.436 (65/266) |
2.47E-10 |
Serine/threonine-protein kinase 32C (STK32C)
|
|
21.898 (60/274) |
2.50E-10 |
Rhodopsin kinase GRK1 (GRK1)
|
|
24.113 (68/282) |
2.74E-10 |
Serine/threonine-protein kinase 32A (STK32A)
|
|
20.807 (67/322) |
2.90E-10 |
Myosin light kinase (MYLK)
|
|
24.569 (57/232) |
3.26E-10 |
Cyclin-dependent kinase-like 2 (CDKL2)
|
|
23.301 (72/309) |
4.04E-10 |
Serine/threonine-protein kinase SBK1 (SBK1)
|
|
25.862 (60/232) |
4.13E-10 |
Stress-activated protein kinase 2b (p38 beta)
|
|
25.311 (61/241) |
4.37E-10 |
Cyclin-dependent kinase 13 (CDK13)
|
|
25.328 (58/229) |
4.55E-10 |
Serine/threonine-protein kinase 17B (STK17B)
|
|
24.625 (82/333) |
4.73E-10 |
Cyclin-dependent kinase 15 (CDK15)
|
|
24.188 (67/277) |
4.94E-10 |
ERK activator kinase 7 (MAP2K7)
|
|
22.813 (73/320) |
6.23E-10 |
Ribosomal protein S6 kinase alpha-4 (RPS6KA4)
|
|
22.531 (73/324) |
7.14E-10 |
Cyclin-dependent kinase 12 (CDK12)
|
|
26.087 (60/230) |
7.48E-10 |
Serine/threonine-protein kinase cot (COT)
|
|
23.469 (69/294) |
7.97E-10 |
Stress-activated protein kinase 2a (p38 alpha)
|
|
25.079 (79/315) |
1.01E-09 |
MEK kinase kinase 2 (MAP4K2)
|
|
24.051 (57/237) |
1.43E-09 |
Hormonally up-regulated neu tumor-associated kinase (HUNK)
|
|
23.009 (52/226) |
1.96E-09 |
Extracellular signal-regulated kinase 5 (ERK5)
|
|
24.786 (58/234) |
2.26E-09 |
Yet another novel kinase 2 (STK32B)
|
|
20.606 (68/330) |
2.27E-09 |
MEK kinase kinase 3 (MAP4K3)
|
|
22.456 (64/285) |
2.33E-09 |
Cytoplasmic DRAK1 (STK17A)
|
|
25.926 (63/243) |
2.57E-09 |
G protein-coupled receptor kinase 4 (GRK4)
|
|
25.664 (58/226) |
2.66E-09 |
Cyclin-dependent kinase 4 (CDK4)
|
|
26.786 (60/224) |
2.81E-09 |
Protein kinase N3 (PKN3)
|
|
25.523 (61/239) |
2.91E-09 |
Cyclin-dependent kinase 20 (CDK20)
|
|
24.786 (58/234) |
2.93E-09 |
MEK kinase kinase 4 (MAP4K4)
|
|
25.296 (64/253) |
2.95E-09 |
Microtubule-associated serine/threonine-protein kinase 3 (MAST3)
|
|
22.712 (67/295) |
3.14E-09 |
Serine/threonine-protein kinase Chk2 (RAD53)
|
|
25.263 (72/285) |
3.69E-09 |
Cyclin-dependent kinase 9 (CDK9)
|
|
23.246 (53/228) |
5.14E-09 |
Mitogen-activated protein kinase kinase kinase kinase 5 (MAP4K5)
|
|
22.807 (65/285) |
5.49E-09 |
Ribosomal protein S6 kinase alpha-5 (RSK5)
|
|
25.000 (60/240) |
5.77E-09 |
Serine/threonine-protein kinase pim-2 (PIM2)
|
|
26.712 (78/292) |
5.99E-09 |
Protein kinase C iota (PRKCI)
|
|
24.034 (56/233) |
8.12E-09 |
Inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE)
|
|
25.203 (62/246) |
8.22E-09 |
MAPK/ERK kinase kinase 4 (MAP3K4)
|
|
21.505 (60/279) |
9.92E-09 |
Serine/threonine-protein kinase tousled-like 1 (TLK1)
|
|
25.907 (50/193) |
1.06E-08 |
Serine/threonine-protein kinase tousled-like 2 (TLK2)
|
|
25.105 (60/239) |
1.12E-08 |
TGF-beta receptor type I (TGFBR1)
|
|
23.100 (76/329) |
1.49E-08 |
Obscurin (OBSCN)
|
|
24.312 (53/218) |
1.56E-08 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha (CAMK2A)
|
|
24.082 (59/245) |
1.61E-08 |
Extracellular signal-regulated kinase 1 (ERK1)
|
|
29.524 (31/105) |
1.76E-08 |
Phosphorylase kinase testis gamma 2 (PHKG2)
|
|
25.974 (60/231) |
2.64E-08 |
Serine/threonine-protein kinase NLK (NLK)
|
|
34.409 (32/93) |
3.21E-08 |
Serine/threonine-protein kinase 35 (STK35)
|
|
24.762 (78/315) |
3.23E-08 |
Mitogen-activated protein kinase 13 (MAPK13)
|
|
25.000 (58/232) |
3.74E-08 |
NF-kappa-B-activating kinase (TBK1)
|
|
26.033 (63/242) |
4.01E-08 |
Mitogen-activated protein kinase 4 (MAPK4)
|
|
26.872 (61/227) |
4.72E-08 |
Serine/threonine-protein kinase D2 (PRKD2)
|
|
25.991 (59/227) |
4.79E-08 |
TBC domain-containing protein kinase-like protein (TBCK)
|
|
22.509 (61/271) |
4.94E-08 |
Ribosomal protein S6 kinase-related protein (RSKR)
|
|
35.106 (33/94) |
5.54E-08 |
Rhodopsin kinase GRK7 (GRK7)
|
|
23.894 (54/226) |
5.77E-08 |
Peripheral plasma membrane protein CASK (CASK)
|
|
24.303 (61/251) |
6.64E-08 |
Extracellular signal-regulated kinase 2 (ERK2)
|
|
28.571 (30/105) |
7.28E-08 |
Bone morphogenetic protein receptor (BMPR2)
|
|
24.927 (85/341) |
7.53E-08 |
Protein kinase D (PRKD1)
|
|
25.110 (57/227) |
1.01E-07 |
Activin receptor type IB (ACVR1B)
|
|
23.361 (57/244) |
1.09E-07 |
Protein kinase C gamma (PRKCG)
|
|
26.761 (38/142) |
1.12E-07 |
Dual specificity protein kinase TTK (MPS1)
|
|
21.201 (60/283) |
1.30E-07 |
CaM-kinase IV kinase (CAMKK1)
|
|
28.758 (44/153) |
1.39E-07 |
Endoplasmic reticulum to nucleus signaling 1 (ERN1)
|
|
28.750 (46/160) |
1.42E-07 |
Microtubule-associated serine/threonine-protein kinase 4 (MAST4)
|
|
22.967 (48/209) |
1.73E-07 |
Calcium/calmodulin-dependent protein kinase type II subunit gamma (CAMK2G)
|
|
23.105 (64/277) |
1.74E-07 |
Microtubule-associated serine/threonine-protein kinase 2 (MAST2)
|
|
21.912 (55/251) |
1.80E-07 |
Calcium/calmodulin-dependent protein kinase type II subunit beta (CAMK2B)
|
|
22.302 (62/278) |
2.47E-07 |
Mitogen-activated protein kinase 15 (MAPK15)
|
|
25.000 (61/244) |
2.49E-07 |
Serine/threonine-protein kinase D3 (PRKD3)
|
|
25.333 (57/225) |
2.64E-07 |
Microtubule-associated serine/threonine-protein kinase 1 (MAST1)
|
|
23.810 (50/210) |
2.91E-07 |
Striated muscle preferentially expressed protein kinase (SPEG)
|
|
24.464 (57/233) |
3.05E-07 |
Eukaryotic translation initiation factor 2-alpha kinase 1 (EIF2AK1)
|
|
30.159 (38/126) |
3.45E-07 |
Serine/threonine-protein kinase WNK1 (WNK1)
|
|
23.707 (55/232) |
4.38E-07 |
Serine/threonine-protein kinase pim-1 (PIM1)
|
|
27.273 (42/154) |
5.56E-07 |
Serine/threonine-protein kinase WNK4 (WNK4)
|
|
23.276 (54/232) |
7.87E-07 |
Cyclin-dependent kinase 11A (CDK11A)
|
|
22.973 (51/222) |
7.95E-07 |
Dual-specificity tyrosine-phosphorylation regulated kinase 3 (DYRK3)
|
|
36.538 (38/104) |
8.38E-07 |
Wee1-like protein kinase 2 (WEE2)
|
|
26.667 (48/180) |
8.60E-07 |
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (PHKG1)
|
|
25.248 (51/202) |
8.79E-07 |
Wee1-like protein kinase (WEE1)
|
|
23.000 (69/300) |
9.05E-07 |
Protein kinase C zeta (PRKCZ)
|
|
21.296 (69/324) |
9.09E-07 |
PRKR-like endoplasmic reticulum kinase (PERK)
|
|
30.303 (30/99) |
1.58E-06 |
Titin (TTN)
|
23.043 (53/230) |
1.70E-06 |
Calcium/calmodulin-dependent protein kinase type II subunit delta (CAMK2D)
|
|
22.857 (56/245) |
1.70E-06 |
Mitogen-activated protein kinase 6 (MAPK6)
|
|
22.467 (51/227) |
1.98E-06 |
MAPK-activated protein kinase 2 (MAPKAPK2)
|
|
27.072 (49/181) |
2.58E-06 |
Homeodomain-interacting protein kinase 4 (HIPK4)
|
|
26.695 (63/236) |
2.76E-06 |
WNK lysine-deficient protein kinase 3 (WNK3)
|
|
22.000 (77/350) |
3.09E-06 |
Cyclin-dependent kinase 11B (CDK11B)
|
|
22.973 (51/222) |
3.47E-06 |
Serine/threonine-protein kinase greatwall (MASTL)
|
|
23.596 (42/178) |
4.74E-06 |
Cyclin-G-associated kinase (GAK)
|
|
20.958 (70/334) |
4.79E-06 |
Cyclin-dependent kinase 19 (CDK19)
|
|
26.271 (62/236) |
5.11E-06 |
Cyclin-dependent kinase 8 (CDK8)
|
|
25.564 (68/266) |
5.47E-06 |
Glycogen synthase kinase-3 alpha (GSK-3A)
|
|
22.041 (54/245) |
7.27E-06 |
Serine/threonine-protein kinase WNK2 (WNK2)
|
|
24.194 (45/186) |
8.78E-06 |
Stress-activated protein kinase JNK3 (JNK3)
|
|
31.183 (29/93) |
8.83E-06 |
CaM kinase-like vesicle-associated protein (CAMKV)
|
|
23.556 (53/225) |
1.02E-05 |
CDC-like kinase 1 (CLK1)
|
|
24.800 (62/250) |
1.14E-05 |
IL-1 receptor-associated kinase 3 (IRAK3)
|
|
21.702 (51/235) |
1.15E-05 |
Anti-mullerian hormone II receptor (AMHR2)
|
|
23.620 (77/326) |
1.32E-05 |
Stress-activated protein kinase JNK1 (JNK1)
|
|
31.183 (29/93) |
1.38E-05 |
Stress-activated protein kinase JNK2 (JNK2)
|
|
31.183 (29/93) |
1.41E-05 |
CDC-like kinase 2 (CLK2)
|
|
22.500 (54/240) |
1.69E-05 |
PAS domain-containing serine/threonine-protein kinase (PASK)
|
|
25.957 (61/235) |
1.77E-05 |
Cyclin-dependent kinase 10 (CDK10)
|
|
23.077 (51/221) |
1.93E-05 |
Casein kinase II alpha (CSNK2A1)
|
|
26.923 (28/104) |
1.94E-05 |
Rho-associated protein kinase 2 (ROCK2)
|
|
23.810 (55/231) |
2.01E-05 |
Citron Rho-interacting kinase (CIT)
|
|
24.638 (68/276) |
2.23E-05 |
Large tumor suppressor homolog 2 (LATS2)
|
|
21.402 (58/271) |
2.42E-05 |
Triple functional domain protein (TRIO)
|
|
23.684 (54/228) |
2.46E-05 |
Glycogen synthase kinase-3 beta (GSK-3B)
|
|
21.702 (51/235) |
2.72E-05 |
Dual-specificity tyrosine-phosphorylation regulated kinase 2 (DYRK2)
|
|
33.645 (36/107) |
2.96E-05 |
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A)
|
|
26.087 (60/230) |
3.01E-05 |
STE20-related kinase adapter protein alpha (STRADA)
|
|
22.222 (48/216) |
3.13E-05 |
Dual-specificity tyrosine-phosphorylation regulated kinase 1B (DYRK1B)
|
|
25.652 (59/230) |
3.71E-05 |
Activin receptor type IIA (ACVR2A)
|
|
23.214 (52/224) |
4.23E-05 |
Rho-associated protein kinase 1 (ROCK1)
|
|
24.242 (56/231) |
4.45E-05 |
Serine/threonine-protein kinase SBK2 (SBK2)
|
|
25.110 (57/227) |
5.49E-05 |
Adaptor-associated kinase 1 (AAK1)
|
|
19.608 (70/357) |
7.22E-05 |
Casein kinase II subunit alpha 3 (CSNK2A3)
|
|
25.962 (27/104) |
7.29E-05 |
Serine/threonine-protein kinase NIK (MAP3K14)
|
|
23.504 (55/234) |
8.05E-05 |
Homeodomain-interacting protein kinase 3 (HIPK3)
|
|
23.729 (56/236) |
8.20E-05 |
Serine/threonine-protein kinase 40 (STK40)
|
|
22.353 (38/170) |
9.45E-05 |
BMP-2-inducible protein kinase (BMP2K)
|
|
21.371 (53/248) |
1.07E-04 |
Serine/threonine kinase-like domain-containing protein STKLD1 (STKLD1)
|
|
25.466 (41/161) |
1.45E-04 |
Serine/threonine-protein kinase PRP4 homolog (PRPF4B)
|
|
25.820 (63/244) |
1.88E-04 |
Serine/threonine-protein kinase LATS1 (LATS1)
|
|
22.543 (39/173) |
2.58E-04 |
Serine/threonine-protein kinase/endoribonuclease IRE2 (ERN2)
|
|
25.773 (75/291) |
3.20E-04 |
Dual-specificity tyrosine-phosphorylation regulated kinase 4 (DYRK4)
|
|
28.972 (31/107) |
3.22E-04 |
CDC-like kinase 4 (CLK4)
|
|
24.481 (59/241) |
3.67E-04 |
Homeodomain interacting protein kinase 2 (HIPK2)
|
|
23.305 (55/236) |
4.07E-04 |
Eukaryotic translation initiation factor 2-alpha kinase 4 (EIF2AK4)
|
|
25.325 (39/154) |
4.69E-04 |
Tribbles homolog 2 (TRIB2)
|
|
24.026 (37/154) |
4.91E-04 |
Homeodomain-interacting protein kinase 1 (HIPK1)
|
|
22.619 (76/336) |
4.97E-04 |
Beta-adrenergic receptor kinase 1 (ADRBK1)
|
|
23.871 (37/155) |
7.97E-04 |
MAPK-activated protein kinase 3 (MAPKAPK3)
|
|
24.167 (29/120) |
1.00E-03 |
Serine/threonine-protein kinase Kist (UHMK1)
|
|
27.273 (33/121) |
1.00E-03 |
Interleukin-1 receptor-associated kinase-like 2 (IRAK2)
|
|
21.212 (49/231) |
1.00E-03 |
CDC-like kinase 3 (CLK3)
|
|
20.940 (49/234) |
2.00E-03 |
MAPK signal-integrating kinase 1 (MKNK1)
|
|
24.219 (62/256) |
3.00E-03 |
Casein kinase II alpha prime (CSNK2A2)
|
|
23.077 (24/104) |
4.00E-03 |
Activin receptor type IIB (ACVR2B)
|
|
25.000 (32/128) |
5.00E-03 |
Click to Show/Hide the Information of Human Similarity Proteins |